Skip to main content

Main menu

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Information for authors
  • About the journal
    • About the journal
    • Editorial board
    • Information for authors
    • FAQs
    • Thank you to our reviewers
      • Thank you to our reviewers
    • American Federation for Medical Research
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
  • BMJ Journals

User menu

  • Login

Search

  • Advanced search
  • BMJ Journals
  • Login
  • Facebook
  • Twitter
JIM

Advanced Search

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Information for authors
  • About the journal
    • About the journal
    • Editorial board
    • Information for authors
    • FAQs
    • Thank you to our reviewers
    • American Federation for Medical Research
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
Open Access

Patient perception of voxelotor treatment benefit in sickle cell disease

Modupe Idowu, Anam Haque, Elisa M Williams, Arthi Sridhar
DOI: 10.1136/jim-2021-002215 Published 22 June 2022
Modupe Idowu
1 Department of Internal Medicine, The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Modupe Idowu
Anam Haque
2 The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa M Williams
2 The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arthi Sridhar
1 Department of Internal Medicine, The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 70 no. 5 1316-1319
DOI 
https://doi.org/10.1136/jim-2021-002215
PubMed 
35732337

Print ISSN 
1081-5589
Online ISSN 
1708-8267
History 
  • Accepted April 1, 2022
  • Published online June 22, 2022.

Copyright & Usage 
© American Federation for Medical Research 2022. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Author Information

  1. Modupe Idowu1,
  2. Anam Haque2,
  3. Elisa M Williams2,
  4. Arthi Sridhar1
  1. 1 Department of Internal Medicine, The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA
  2. 2 The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA
  1. Correspondence to Dr Modupe Idowu, Department of Internal Medicine, The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, TX 77030, USA; modupe.idowu{at}uth.tmc.edu
View Full Text

Article usage

Article usage: June 2022 to July 2023

AbstractFullPdf
Jun 202222722752
Jul 202217016494
Aug 202214314244
Sep 2022969942
Oct 2022746932
Nov 2022807226
Dec 2022695920
Jan 2023343720
Feb 2023575731
Mar 2023212420
Apr 2023222315
May 2023333218
Jun 202315139
Jul 2023004

Statistics from Altmetric.com

PreviousNext
Back to top
Vol 70 Issue 5 Table of Contents
Journal of Investigative Medicine: 70 (5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • AFMR Highlights
  • Front Matter (PDF)
Email

Thank you for your interest in spreading the word on JIM.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Patient perception of voxelotor treatment benefit in sickle cell disease
(Your Name) has sent you a message from JIM
(Your Name) thought you would like to see the JIM web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Patient perception of voxelotor treatment benefit in sickle cell disease
Modupe Idowu, Anam Haque, Elisa M Williams, Arthi Sridhar
Journal of Investigative Medicine Jun 2022, 70 (5) 1316-1319; DOI: 10.1136/jim-2021-002215

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Cite This
  • APA
  • Chicago
  • Endnote
  • MLA
Loading
Patient perception of voxelotor treatment benefit in sickle cell disease
Modupe Idowu, Anam Haque, Elisa M Williams, Arthi Sridhar
Journal of Investigative Medicine Jun 2022, 70 (5) 1316-1319; DOI: 10.1136/jim-2021-002215
Download PDF

Share
Patient perception of voxelotor treatment benefit in sickle cell disease
Modupe Idowu, Anam Haque, Elisa M Williams, Arthi Sridhar
Journal of Investigative Medicine Jun 2022, 70 (5) 1316-1319; DOI: 10.1136/jim-2021-002215
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Article
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Ethics statements
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011–2020
  • Is blood lymphocyte count a prognostic biomarker in Staphylococcus aureus bacteremia?
  • Effect of intramuscular depot betamethasone injection in patients with fibromyalgia and elevated C-reactive protein levels
Show more Brief report

Similar Articles

 

CONTENT

  • Latest content
  • Current issue
  • Archive
  • Sign up for email alerts
  • RSS

JOURNAL

  • About the journal
  • Editorial board
  • Subscribe
  • Thank you to our reviewers
  • American Federation for Medical Research

AUTHORS

  • Information for authors
  • Submit a paper
  • Track your article
  • Open Access at BMJ

HELP

  • Contact us
  • Reprints
  • Permissions
  • Advertising
  • Feedback form

© 2023 American Federation for Medical Research